L608 not checked

Pharmosa Biopharm Inc.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
1 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Participants will receive L608 TID over 28 consecutive days.”In the company’s words, NCT07925619 on ClinicalTrials.gov
Tested for
Systemic Sclerosis
Main trialPhase 2
“This trial is designed to evaluate the efficacy and safety of L608 compared to placebo in patients with SSc-DU.”In the company’s words, NCT07925619 on ClinicalTrials.gov

Other drugs for Systemic Sclerosis

All 57 drugs for Systemic Sclerosis

Coming up1

Changes1

Last 90 days

Trials1

TrialPhaseCompletesWhat it tests
Phase 2Not yet recruiting 31 Dec 2028 Efficacy and Safety Study of L608 in Patients With Systemic Sclerosis-associated Digital Ulcers
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow L608

Following is part of Solo: you see every change to L608 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in